China (Mainland)
Premiumsupplier 
High purity Bortezomib 179324-69-7 CAS NO.179324-69-7
- FOB Price: USD: 1.00-1.00 /Metric Ton Get Latest Price
- Min.Order: 100 Gram
- Payment Terms: L/C,T/T,MoneyGram
- Available Specifications:
99%(100-500)Metric Ton
- Product Details
Keywords
- Bortezomib
- VELCADE
- [(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid
Quick Details
- ProName: High purity Bortezomib 179324-69-7
- CasNo: 179324-69-7
- Molecular Formula: C19H25BN4O4
- Appearance: White or almost white powder
- Application: Pharmaceutical raw materials , Oncolog...
- DeliveryTime: prompt shipment
- PackAge: Double plastic bag inside ,Aluminum fo...
- Port: China Main Port
- ProductionCapacity: 2000 Kilogram/Month
- Purity: 99%min
- Storage: RT.
- Transportation: BY AIR
- LimitNum: 100 Gram
- Related Substances: not avaliable
- Residue on Ignition: not avaliable
- Heavy Metal: not avaliable
- Valid Period: 2 years
- CAS No.: 179324-69-7
Superiority
Bortezomib
| Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. |
Assay no less than 99%
CAS :179324-69-7
MW:C19H25BN4O4
MF :384.2372
Quality standard:USP
Details
Bortezomib
Assay no less than 99%
CAS :179324-69-7
MW:C19H25BN4O4
MF :384.2372
Quality standard:USP
Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
| product Name | Bortezomib |
|---|---|
| Synonyms | VELCADE; dpba; [(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid; VELCADE(BORTEZOMIB); Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Bortezomib for research; N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide |
| Molecular Formula | C19H25BN4O4 |
| Molecular Weight | 384.2372 |
| InChI | InChI=1/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1 |
| CAS Registry Number | 179324-69-7 |
| Molecular Structure |
|
| Density | 1.214g/cm3 |
| Melting point | 122-124℃ |
| Refractive index | 1.564 |
